142.23
price down icon3.95%   -5.85
after-market Handel nachbörslich: 142.23
loading
Schlusskurs vom Vortag:
$148.08
Offen:
$145.54
24-Stunden-Volumen:
812.54K
Relative Volume:
0.49
Marktkapitalisierung:
$19.40B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-80.81
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
-4.19%
1M Leistung:
-5.90%
6M Leistung:
+18.03%
1J Leistung:
+66.78%
1-Tages-Spanne:
Value
$140.85
$147.06
1-Wochen-Bereich:
Value
$140.85
$152.66
52-Wochen-Spanne:
Value
$85.09
$183.00

Natera Inc Stock (NTRA) Company Profile

Name
Firmenname
Natera Inc
Name
Telefon
650-249-9090
Name
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Name
Mitarbeiter
4,434
Name
Twitter
@nateragenetics
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NTRA's Discussions on Twitter

Vergleichen Sie NTRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NTRA
Natera Inc
142.23 19.40B 1.53B -214.69M -43.68M -1.76
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
421.85 169.62B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
184.96 138.06B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
406.65 32.79B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
100.26 29.99B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
141.22 26.61B 15.41B 1.37B 2.11B 7.50

Natera Inc Stock (NTRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet RBC Capital Mkts Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-08 Fortgesetzt Craig Hallum Buy
2024-02-20 Herabstufung Raymond James Strong Buy → Outperform
2023-12-29 Bestätigt BTIG Research Buy
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-11-13 Hochstufung Raymond James Outperform → Strong Buy
2023-09-28 Eingeleitet Bernstein Mkt Perform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-05 Eingeleitet UBS Buy
2023-01-18 Hochstufung Raymond James Mkt Perform → Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Eingeleitet Stephens Overweight
2022-03-08 Eingeleitet Goldman Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-28 Eingeleitet Truist Buy
2020-10-08 Eingeleitet BTIG Research Buy
2020-09-28 Eingeleitet Morgan Stanley Overweight
2020-09-17 Eingeleitet SVB Leerink Outperform
2020-06-10 Fortgesetzt Piper Sandler Overweight
2020-05-07 Hochstufung JP Morgan Neutral → Overweight
2018-10-05 Eingeleitet JP Morgan Neutral
2018-07-05 Bestätigt Piper Jaffray Overweight
2017-08-07 Bestätigt Morgan Stanley Overweight
2016-11-10 Bestätigt The Benchmark Company Buy
2016-05-23 Bestätigt The Benchmark Company Buy
2016-05-11 Bestätigt The Benchmark Company Buy
2016-04-19 Eingeleitet The Benchmark Company Buy
2015-09-28 Hochstufung Wedbush Neutral → Outperform
2015-08-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-08-04 Eingeleitet Robert W. Baird Outperform
2015-07-27 Eingeleitet Morgan Stanley Equal-Weight
2015-07-27 Eingeleitet Piper Jaffray Overweight
2015-07-27 Eingeleitet Wedbush Neutral
Alle ansehen

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
Apr 18, 2025

Long Term Trading Analysis for (NTRA) - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

The Blood Test Revolution Driving These Three Stocks - Investor's Business Daily

Apr 17, 2025
pulisher
Apr 16, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 16, 2025
pulisher
Apr 15, 2025

Lobbying Update: $140,000 of NATERA INC lobbying was just disclosed - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

When will cancer return? Personalized Signatera blood test can find early signs of disease - Austin American-Statesman

Apr 15, 2025
pulisher
Apr 12, 2025

Natera (NasdaqGS:NTRA) Climbs 11% in One Week - simplywall.st

Apr 12, 2025
pulisher
Apr 10, 2025

Barclays Adjusts Natera (NTRA) Price Target Amid Industry Challe - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Assessing Natera: Insights From 10 Financial Analysts - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit? - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Natera price target lowered to $160 from $200 at Barclays - TipRanks

Apr 10, 2025
pulisher
Apr 08, 2025

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

3 Reasons NTRA Has Explosive Upside Potential - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 07, 2025

15 Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey

Apr 07, 2025
pulisher
Apr 07, 2025

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks - Yahoo Finance

Apr 07, 2025
pulisher
Apr 07, 2025

Immuno-Oncology Stocks Weather Market Volatility Despite Strong Q4News and Statistics - IndexBox

Apr 07, 2025
pulisher
Apr 07, 2025

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY) - Yahoo Finance

Apr 07, 2025
pulisher
Apr 06, 2025

Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com

Apr 06, 2025
pulisher
Apr 06, 2025

Insider Selling: Natera, Inc. (NASDAQ:NTRA) CFO Sells 2,562 Shares of Stock - MarketBeat

Apr 06, 2025
pulisher
Apr 04, 2025

Natera co-founder Sheena Jonathan sells $826,326 in stock By Investing.com - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

Natera co-founder Sheena Jonathan sells $826,326 in stock - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

Is the Market Bullish or Bearish on Natera? - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

Natera’s president of clinical diagnostics sells $421,428 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Natera director Marcus Gail boxer sells $563,100 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Natera director Marcus Gail boxer sells $563,100 in stock - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Natera’s president of clinical diagnostics sells $421,428 in stock - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Natera Inc (NTRA) Shares Up 3.33% on Apr 2 - GuruFocus

Apr 02, 2025
pulisher
Apr 01, 2025

Natera CFO Michael Burkes sells $354,603 in stock By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Natera CEO Steven Leonard sells $3.56 million in stock By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Natera’s chief legal officer Daniel Rabinowitz sells $194,326 in stock By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Natera CEO Steven Leonard sells $3.56 million in stock - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Natera CFO Michael Burkes sells $354,603 in stock - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 27, 2022 in Natera LawsuitNTRA - Newsfile

Apr 01, 2025
pulisher
Apr 01, 2025

Is Natera, Inc. (NASDAQ:NTRA) Trading At A 23% Discount? - simplywall.st

Apr 01, 2025
pulisher
Apr 01, 2025

Transforming Colorectal Cancer Management with Tumor-Informed ctDNA Testing - Inside Precision Medicine

Apr 01, 2025
pulisher
Apr 01, 2025

Natera’s chief legal officer Daniel Rabinowitz sells $194,326 in stock - Investing.com

Apr 01, 2025
pulisher
Mar 30, 2025

Quantbot Technologies LP Makes New $878,000 Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

EFG Asset Management North America Corp. Sells 9,323 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Mar 29, 2025
pulisher
Mar 25, 2025

Game-Changing Heart Transplant Monitoring Trial Results: 1,100+ Patient Study Could Transform Post-Surgery Care - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

Natera’s Busy 2025 Continues - The Healthcare Technology Report.

Mar 25, 2025
pulisher
Mar 25, 2025

(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate

Mar 25, 2025
pulisher
Mar 24, 2025

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law News

Mar 24, 2025
pulisher
Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025
pulisher
Mar 21, 2025

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance

Mar 20, 2025

Finanzdaten der Natera Inc-Aktie (NTRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$212.22
price down icon 2.26%
diagnostics_research WAT
$316.23
price down icon 1.49%
diagnostics_research DGX
$161.86
price down icon 1.18%
diagnostics_research MTD
$970.15
price down icon 3.46%
diagnostics_research IQV
$141.22
price down icon 1.87%
Kapitalisierung:     |  Volumen (24h):